Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Kyorin and Eisai sign license agreement for Uritos for overactive bladder

Oct. 1, 2009

Keryx reports results of open-label extension study of Zerenex for hyperphosphatemia

Sep. 29, 2009

Roche claims alpha1A-adrenoceptor partial agonists for the treatment of urinary incontinence

Sep. 25, 2009

Protox Therapeutics presents 12-month phase II PRX-302 results

Sep. 17, 2009

U.K. launch for Regurin XL for overactive bladder

Sep. 8, 2009

Japanese launch for GSK's dutasteride for benign prostatic hyperplasia

Sep. 7, 2009

Light Sciences Oncology treats patients in phase II Aptocine trial in BPH

Aug. 20, 2009

Sitaxsentan treatment has multiple benefits in chronic kidney disease

Aug. 20, 2009

AEterna reports results from two phase III cetrorelix studies in BPH

Aug. 18, 2009

Hisamitsu reports results from phase II study of HOB-294 in overactive bladder

Aug. 11, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...